{"prompt": "['Study Number: GSP 301-305', 'Version 3.0', 'Date 18-Jul-2018', '11.1.8.', 'Confirmation of Medical Care by Another Physician', 'The Investigator will instruct subjects (parents/legal guardians/caregivers, as applicable) to', 'inform site personnel when they are planning to receive medical care by another physician. At', 'each visit, the Investigator will ask the subject whether he/she has received medical care by', 'another physician since the last visit or is planning to do so in the future (parents/legal', 'guardians/caregivers, as applicable). When the subject is going to receive medical care by', 'another physician, the Investigator, with the consent of the subject (parents/legal', 'guardians/caregivers, as applicable), will inform the other physician that the subject is', 'participating in the clinical study.', '11.2.', 'Adverse and Serious Adverse Events', 'The Investigator or site staff will be responsible for detecting, documenting, and reporting events', 'that meet the definition of an AE or SAE.', 'The reference safety information for this study is provided in the Investigational Brochure', 'Section 6.4.8.2 within the Summary of Data and Guidance for Investigators Definition of', 'Adverse Events (GSP 301 IB, 2017).', 'List of contact details are provided in Appendix 2.', '11.2.1.', 'Adverse Event', 'An AE is defined as any untoward medical occurrence in a subject administered study drug that', 'does not necessarily have a causal relationship with the treatment. An AE can, therefore, be any', 'unfavorable and unintended sign (including an abnormal laboratory finding), symptom or disease', '(new or exacerbated) temporally associated with the use of the study drug, whether or not related', 'to the study drug. An AE includes any event, regardless of the presumed causality between the', 'event and the study drug.', 'Events that, while not necessarily meeting the definition of AEs, should be treated as such', 'because they may be reportable to Regulatory Authorities according to AE reporting regulations,', 'whether or not considered causally associated with IP, include the following:', 'Study drug overdose, whether accidental or intentional', 'Study drug abuse', 'An event occurring from study drug withdrawal', 'Any failure of expected pharmacological action', 'Inadvertent or accidental study drug exposure (eg, product leaking or being spilled', 'onto a subject or care-giver)', 'Unexpected therapeutic or clinical benefit from the study drug', 'Medication errors (ie, incorrect route of administration, incorrect dosage, use of', 'incorrect product).', 'Events that do not meet the definition of an AE include:', 'Glenmark', 'CONFIDENTIAL', 'Page 50 of 90']['Study Number: GSP 301-305', 'Version 3.0', 'Date 18-Jul-2018', 'Medical or surgical procedure (eg, endoscopy, appendectomy); the condition that', 'leads to the procedure is an AE', 'Situations where an untoward medical occurrence did not occur (social and/or', 'convenience admission to a hospital)', 'Anticipated day-to-day fluctuations of pre-existing disease(s) or condition(s) present', 'or detected at the start of the study that do not worsen', 'The disease/disorder being studied or expected progression, signs, or symptoms of', 'the', \"disease/disorder being studied, unless more severe than expected for the subject's\", 'condition.', 'Note that significant worsening of symptoms (ie, requiring systemic steroids, antibiotics, or', 'hospitalization) will be reported as an AE.', '11.2.1.1. Assessment of Severity of Adverse Events', 'The severity of AEs is classified as follows:', 'Mild:', '-', 'The AE is a transient discomfort and does not interfere in a significant manner', 'with the subject.', '-', 'The AE resolves spontaneously or may require minimal therapeutic intervention.', 'Moderate:', '- The AE produces limited impairment of function and may require therapeutic', 'intervention.', '- The AE produces no sequelae.', 'Severe:', '- The AE results in a marked impairment of function and may lead to temporary', 'inability to resume usual life pattern.', '-', 'The AE produces sequelae, which require (prolonged) therapeutic intervention.', 'The criteria for assessing severity are different from those used for seriousness (see', 'Section 11.2.1.2 for the definition of an SAE).', '11.2.1.2. Serious Adverse Event', 'An SAE is any untoward medical occurrence that, at any dose:', 'Results in death.', 'Is life-threatening.', '-', 'NOTE: The term \"life-threatening\\' in the definition of \\'serious\\' refers to an event in', 'which the subject was at risk of death at the time of the event. It does not refer to', 'an event, which hypothetically might have caused death, if it were more severe.', 'Glenmark', 'CONFIDENTIAL', 'Page 51 of 90']\n\n###\n\n", "completion": "END"}